Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity

白细胞整合素信号的改变导致糖尿病和自身免疫

基本信息

项目摘要

Project Summary/Abstract The study of the genetic basis for type 1 diabetes (T1D) has benefited tremendously from examination of rare individuals with likely monogenic forms of the disease. Combined with GWAS, a number of polymorphisms in immune regulatory genes have been defined that contribute to genetic risk for T1D. Using whole exome sequencing of individuals with T1D enrolled in a monogenic diabetes registry, we identified an individual with a gain-of-function mutation in the SKAP2 gene, as well as several other T1D patients with potentially pathogenic variants in other leukocyte integrin signaling genes. These patients tend to have a number of autoimmune manifestations in addition to T1D, indicating defects in critical pathways of immune tolerance. Multiple GWAS studies have identified a strong genetic linkage between SKAP2 polymorphisms and T1D (at a frequency of ~20%), however the mechanisms by which alteration of SKAP2 could lead to autoimmune T1D are unknown. SKAP2 is expressed primarily in myeloid cells, where it functions as an adapter protein in the integrin signaling pathway, linking cell surface integrins to WASP and actin rearrangements that occur following leukocyte adhesion. The SKAP2 G153R mutation in our patient resulted in constitutive association of SKAP2 with WASP leading to a hyperadhesive phenotype in macrophages cultured from the patient or macrophages engineered to contain the SKAP G153R substitution. To understand how activation of leukocyte integrin signaling may contribute to T1D, we have generated knock-in (KI) mice containing the G153R substitution in murine Skap2, on the NOD genetic background. Female NOD.SKAP2 KI mice have a higher incidence and earlier onset of T1D than do NOD.WT animals; male NOD.SKAP2 also develop T1D (incidence ~50%) while male NOD.WT do not develop frank hyperglycemia. Initial analysis of these mice reveals evidence of ongoing inflammation early in life with development of a broad spectrum of auto-reactive antibodies. Dendritic cells from NOD.SKAP2 KI mice have increased antigen presenting activity to islet-specific transgenic T-cells while neutrophils from these mice show evidence of increased integrin signaling. These observations demonstrate that the NOD.SKAP2 KI mice appropriately model the autoimmune T1D disease observed in our patient. The project proposes to complete the analysis of these mice, under the hypothesis that increased cell adhesion in dendritic cells leads to prolonged DC-T cell interactions, which drives selection of auto-reactive T-cell clones leading to development of T1D, associated with broad spectrum autoimmunity. We will test this hypothesis in a variety of adoptive cell transfer experiments, by generation of conditional knock-in mice and by imaging of DC-T cell interactions in the inflamed islets. Similar studies will be performed for other candidate leukocyte integrin signaling mutations identified in the monogenic T1D registry. This study will address whether dysregulation of leukocyte integrin signaling may constitute an unrecognized genetic risk factor for T1D, suggesting potential alterative therapeutic approaches for these patients.
项目摘要/摘要 1型糖尿病(T1D)的遗传基础的研究从罕见的检查中受益匪浅 具有可能是单基因疾病形式的个体。结合GWAS,许多多态性 已经定义了有助于T1D的遗传风险的免疫调节基因。使用整个外显子 在单基因糖尿病注册表中注册T1D的个体的测序,我们确定了一个患有A的个体 SKAP2基因的功能性突变以及其他可能致病性的其他T1D患者 其他白细胞整联蛋白信号基因中的变体。这些患者往往有多种自身免疫性 除T1D外,表现表明免疫耐受性的临界途径缺陷。多个GWAS 研究已经确定了SKAP2多态性与T1D之间的固有稳定的联系(以 〜20%),但是,SKAP2改变可能导致自身免疫性T1D的机制尚不清楚。 SKAP2主要在髓样细胞中表达,在整联蛋白信号传导中,它充当衔接蛋白 途径,将细胞表面整合素与白细胞后发生的WASP和肌动蛋白重排 粘附。我们患者中的SKAP2 G153R突变导致SKAP2与WASP的组成型关联 导致由患者或巨噬细胞培养的巨噬细胞中的高粘着表型 包含SKAP G153R替代。了解白细胞整合素信号的激活如何 有助于T1D,我们已经产生了含G153R替代的Murine Skap2中的敲入(Ki)小鼠, 在点头遗传背景上。雌性点头skap2 ki小鼠的发病率更高,发病较早 T1D比点头动物;男性点头。SKAP2还会发展T1D(发病率〜50%),而男性点头。 不要发展Frank Hyperglycemia。对这些小鼠的初步分析揭示了持续炎症的证据 生命的早期,随着各种自身反应性抗体的发展。树突状细胞来自 NOD.SKAP2 KI小鼠具有增加对胰岛特异性转基因T细胞的抗原活性,而 这些小鼠的中性粒细胞显示了整联蛋白信号增加的证据。这些观察结果证明了 对我们患者观察到的自身免疫性T1D疾病适当地模拟了点头。这 项目提议完成对这些小鼠的分析,这是假设增加了细胞粘附的假设 树突状细胞会导致长时间的DC-T细胞相互作用,该相互作用驱动自动反应性T细胞克隆的选择 导致T1D的发展,与广泛自身免疫有关。我们将在 通过有条件的敲击小鼠以及成像的各种收养细胞转移实验 发炎胰岛中的DC-T细胞相互作用。其他候选白细胞将进行类似的研究 单基因T1D注册表中确定的整合素信号传导突变。这项研究将解决是否 白细胞整联蛋白信号传导失调可能构成T1D的未识别遗传危险因素 为这些患者提出潜在的改变治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark S Anderson其他文献

Mark S Anderson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark S Anderson', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10328098
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Project 2: STAT3 as a trigger for T1D
项目 2:STAT3 作为 T1D 的触发因素
  • 批准号:
    10576386
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
STAT3 variants as a rheostat of immune tolerance
STAT3 变体作为免疫耐受的变阻器
  • 批准号:
    10328097
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
调整 1 型糖尿病 T 细胞耐受性的肽特异性
  • 批准号:
    10630946
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Project 2: STAT3 as a trigger for T1D
项目 2:STAT3 作为 T1D 的触发因素
  • 批准号:
    10328102
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Core A: Mouse Core
核心A:鼠标核心
  • 批准号:
    10328099
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
调整 1 型糖尿病 T 细胞耐受性的肽特异性
  • 批准号:
    10503923
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
  • 批准号:
    10683384
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Core A: Mouse Core
核心A:鼠标核心
  • 批准号:
    10576378
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
STAT3 variants as a rheostat of immune tolerance
STAT3 变体作为免疫耐受的变阻器
  • 批准号:
    10576375
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:

相似海外基金

Molecular Mechanisms of Myoblast Fusion
成肌细胞融合的分子机制
  • 批准号:
    10928438
  • 财政年份:
    2023
  • 资助金额:
    $ 64.67万
  • 项目类别:
Poldip2 and the Brain Endothelial Barrier Function: Understanding Mechanisms that Regulate the Blood Brain Barrier Integrity
Poldip2 和脑内皮屏障功能:了解调节血脑屏障完整性的机制
  • 批准号:
    10658239
  • 财政年份:
    2023
  • 资助金额:
    $ 64.67万
  • 项目类别:
Defining WASp-dependent pathways in replication stress
定义复制应激中的 WASp 依赖性途径
  • 批准号:
    10708353
  • 财政年份:
    2023
  • 资助金额:
    $ 64.67万
  • 项目类别:
LIM domain kinases: regulation and substrate recognition
LIM 结构域激酶:调节和底物识别
  • 批准号:
    10443356
  • 财政年份:
    2022
  • 资助金额:
    $ 64.67万
  • 项目类别:
Molecular Mechanisms of corneal wound repair
角膜伤口修复的分子机制
  • 批准号:
    10296958
  • 财政年份:
    2021
  • 资助金额:
    $ 64.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了